A new iScience study shows that the RNA acetyltransferase NAT10 stabilizes PCSK9 mRNA through N4-acetylcytidine modification, ...
A transcriptomic reprogramming screen has identified the RNA splicing factor SRSF1 as a conserved regulator of aging that ...
Spread the loveImagine a world where detecting deadly viruses like HIV, influenza, or even the next emergent pathogen isn’t a ...
A study led by Heidelberg University found that small genetic changes can give simple RNA droplets cavities, movement and cargo uptake, opening new possibilities for synthetic biology and future ...
A small number of random genetic mutations cause simple RNA droplets to transform into cell-like structures. In this process, ...
A new study has identified RUNX1 (RUNX family transcription factor 1) as a key driver of a harmful fibroblast state in skin fibrosis. The work shows that these cells adapt to stress, avoid a form of ...
Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...
A new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially important biomarker and therapeutic target across gastrointestinal cancers.
Oxford biotech secures $47 million to scale cell-based mRNA manufacturing, with an eye on therapies that require repeated ...
COVID-19 accelerated efforts to develop faster, more efficient ways of manufacturing high-quality RNA sequences.
A chemical mark placed on messenger ribonucleic acid (mRNA) helps alfalfa coordinate stem growth with the way it distributes ...
The data establish the first clinical proof-of-mechanism for RNA activation (RNAa) in a human monogenic disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results